Literature DB >> 6295926

Mechanisms of tumour cell destruction by PMA-activated human neutrophils.

F Dallegri, G Frumento, F Patrone.   

Abstract

Phorbol myristate acetate (PMA)-activated neutrophils were found to destroy B lymphoblast tumour cells (Raji) as determined by the 51Cr release assay. The target cell lysis was prevented by azide, suggesting the involvement of the myeloperoxidase enzyme. Catalase and cytochrome c caused a marked impairment of the neutrophil-mediated cytolysis, whereas superoxide dismutase significantly enhanced the target cell destruction. These data indicate that hydrogen peroxide plays a key role in the target cell injury; superoxide anion appears to be devoid of direct cytotoxic activity, despite its requirement as a precursor of hydrogen peroxide. The target cell destruction required the presence of the iodide ion as oxidizable co-factor for the myeloperoxidase-hydrogen peroxide system. The chloride ion alone was uneffective. Inhibition of target cell metabolic pathways, involved in the cellular defences against oxidative injury, by the anti-neoplastic agent 1,3-bis-(2-chloroethyl)-1-nitrosurea (BCNU) resulted in an increased neutrophil-mediated cytolysis. Under the experimental conditions employed, PMA-activated neutrophils incubated with BCNU-treated Raji cells became cytotoxic also in the presence of the chloride ion alone as myeloperoxidase co-factor. Our results suggest that Raji target cell destruction by PMA-activated neutrophils depends on the myeloperoxidase-hydrogen peroxide-halide system. The cytolytic event is influenced by target cells themselves, which should be regarded as an active component of the cytotoxic system, capable of interfering with the lytic mediators of the effector cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6295926      PMCID: PMC1453919     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  D L Nelson; B M Bundy; H E Pitchon; R M Blaese; W Strober
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  Chlorination by the myeloperoxidase-H2O2-Cl- antimicrobial system at acid and neutral pH.

Authors:  J M Zgliczynski; R J Selvaraj; B B Paul; T Stelmaszynska; P K Poskitt; A J Sbarra
Journal:  Proc Soc Exp Biol Med       Date:  1977-03

3.  Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity.

Authors:  R P Gale; J Zighelboim
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

4.  Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea].

Authors:  H Frischer; T Ahmad
Journal:  J Lab Clin Med       Date:  1977-05

5.  Lysis of antibody-treated human erythrocytes by human leukocytes and macrophages in tissue culture.

Authors:  G Holm
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

6.  A test of granulocyte membrane integrity and phagocytic function.

Authors:  F Dankberg; M D Persidsky
Journal:  Cryobiology       Date:  1976-08       Impact factor: 2.487

7.  Immunologic rejection of mammary adenocarcinoma (TA3-St) in C57BL/6 mice: participation of neutrophils and activated macrophages with fibrin formation.

Authors:  A M Dvorak; A B Connell; K Proppe; H F Dvorak
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

8.  Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells.

Authors:  R A Clark; S J Klebanoff; A B Einstein; A Fefer
Journal:  Blood       Date:  1975-02       Impact factor: 22.113

Review 9.  Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: the key role of superoxide dismutase.

Authors:  B Halliwell
Journal:  Cell Biol Int Rep       Date:  1978-03

10.  Iodination of bacteria: a bactericidal mechanism.

Authors:  S J Klebanoff
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

View more
  10 in total

1.  Tumor entrained neutrophils inhibit seeding in the premetastatic lung.

Authors:  Zvi Granot; Erik Henke; Elizabeth A Comen; Tari A King; Larry Norton; Robert Benezra
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

2.  Study of the oxidative metabolic function and chemotaxis of neutrophils from patients with cancer influenced by selenium yeast.

Authors:  H B Xu; W D Mei; Z M Dong; B L Liao
Journal:  Biol Trace Elem Res       Date:  1990-06       Impact factor: 3.738

3.  Superoxide production of polymorphonuclear leukocytes in surgical patients with gastric cancer.

Authors:  T Nakagoe; S Watabe; M Tomita; A Tomonaga; T Kitamura
Journal:  Gastroenterol Jpn       Date:  1986-04

4.  Role of oxygen intermediates in cytotoxicity: studies in chronic granulomatous disease.

Authors:  R L Roberts; B J Ank; M W Fanger; L Shen; E R Stiehm
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

5.  The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment.

Authors:  Ronit Vogt Sionov; Zvi G Fridlender; Zvi Granot
Journal:  Cancer Microenviron       Date:  2014-06-04

6.  Resistance of human tumor cells in vitro to oxidative cytolysis.

Authors:  J O'Donnell-Tormey; C J DeBoer; C F Nathan
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Participation of polymorphonuclear leukocyte-derived factor in murine tumour cell killing.

Authors:  M Ikenami; M Yamazaki
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

8.  Cytotoxin from polymorphonuclear leukocytes and inflammatory ascitic fluids.

Authors:  M Yamazaki; M Ikenami; T Sugiyama
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

9.  Self-Guided Supramolecular Cargo-Loaded Nanomotors with Chemotactic Behavior towards Cells.

Authors:  Fei Peng; Yingfeng Tu; Jan C M van Hest; Daniela A Wilson
Journal:  Angew Chem Int Ed Engl       Date:  2015-08-14       Impact factor: 15.336

10.  Jungle honey enhances immune function and antitumor activity.

Authors:  Miki Fukuda; Kengo Kobayashi; Yuriko Hirono; Mayuko Miyagawa; Takahiro Ishida; Emenike C Ejiogu; Masaharu Sawai; Kent E Pinkerton; Minoru Takeuchi
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.